You are here

Article info

Article menu
Basic tumor immunology
Original research
Switch receptor T3/28 improves long-term persistence and antitumor efficacy of CAR-T cells

Authors

  • Songbo Zhao Key Laboratory for Experimental Teratology of Ministry of Education, Shandong Key Laboratory of Infection and Immunity, and Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China PubMed articlesGoogle scholar articles
  • Chunhua Wang Institute of Marine Science and Technology, Shandong University, Qingdao, Shandong, China PubMed articlesGoogle scholar articles
  • Ping Lu Department of Hematology, Zibo Central Hospital, Zibo, Shandong, China PubMed articlesGoogle scholar articles
  • Yalin Lou Key Laboratory for Experimental Teratology of Ministry of Education, Shandong Key Laboratory of Infection and Immunity, and Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China PubMed articlesGoogle scholar articles
  • Huimin Liu Key Laboratory for Experimental Teratology of Ministry of Education, Shandong Key Laboratory of Infection and Immunity, and Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China PubMed articlesGoogle scholar articles
  • Ting Wang Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China PubMed articlesGoogle scholar articles
  • Shanshan Yang Key Laboratory for Experimental Teratology of Ministry of Education, Shandong Key Laboratory of Infection and Immunity, and Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China PubMed articlesGoogle scholar articles
  • Ziyou Bao Key Laboratory for Experimental Teratology of Ministry of Education, Shandong Key Laboratory of Infection and Immunity, and Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China PubMed articlesGoogle scholar articles
  • Lin Han Institute of Marine Science and Technology, Shandong University, Qingdao, Shandong, China PubMed articlesGoogle scholar articles
  • Xiaohong Liang Key Laboratory for Experimental Teratology of Ministry of Education, Shandong Key Laboratory of Infection and Immunity, and Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China PubMed articlesGoogle scholar articles
  • Chunhong Ma Key Laboratory for Experimental Teratology of Ministry of Education, Shandong Key Laboratory of Infection and Immunity, and Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China PubMed articlesGoogle scholar articles
  • Lifen Gao Key Laboratory for Experimental Teratology of Ministry of Education, Shandong Key Laboratory of Infection and Immunity, and Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Lifen Gao; glfflg{at}sdu.edu.cn
View Full Text

Citation

Zhao S, Wang C, Lu P, et al
Switch receptor T3/28 improves long-term persistence and antitumor efficacy of CAR-T cells
Journal for ImmunoTherapy of Cancer 2021;9:e003176. doi: 10.1136/jitc-2021-003176

Publication history

  • Accepted November 4, 2021
  • First published December 1, 2021.
Online issue publication 
October 25, 2022

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.